Dasatinib, sold under the brand name Sprycel, is a chemotherapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).
This report aims to provide a comprehensive presentation of the global market for Dasatinib Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dasatinib Drugs. This report contains market size and forecasts of Dasatinib Drugs in global, including the following market information:
Global Dasatinib Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Dasatinib Drugs Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Dasatinib Drugs companies in 2022 (%)
The global Dasatinib Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
20mg Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Dasatinib Drugs include Bristol-Myers Squibb and LUCIUS Pharma etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dasatinib Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dasatinib Drugs Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Dasatinib Drugs Market Segment Percentages, by Type, 2022 (%)
20mg
50mg
70mg
Global Dasatinib Drugs Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Dasatinib Drugs Market Segment Percentages, by Application, 2022 (%)
CML
ALL
Global Dasatinib Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Dasatinib Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dasatinib Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Dasatinib Drugs revenues share in global market, 2022 (%)
Key companies Dasatinib Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Dasatinib Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
LUCIUS Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dasatinib Drugs, market overview.
Chapter 2: Global Dasatinib Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Dasatinib Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dasatinib Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Dasatinib Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Dasatinib Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dasatinib Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dasatinib Drugs Overall Market Size
2.1 Global Dasatinib Drugs Market Size: 2022 VS 2030
2.2 Global Dasatinib Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Dasatinib Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Dasatinib Drugs Players in Global Market
3.2 Top Global Dasatinib Drugs Companies Ranked by Revenue
3.3 Global Dasatinib Drugs Revenue by Companies
3.4 Global Dasatinib Drugs Sales by Companies
3.5 Global Dasatinib Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Dasatinib Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Dasatinib Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dasatinib Drugs Players in Global Market
3.8.1 List of Global Tier 1 Dasatinib Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Dasatinib Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Dasatinib Drugs Market Size Markets, 2022 & 2030
4.1.2 20mg
4.1.3 50mg
4.1.4 70mg
4.2 By Type - Global Dasatinib Drugs Revenue & Forecasts
4.2.1 By Type - Global Dasatinib Drugs Revenue, 2018-2023
4.2.2 By Type - Global Dasatinib Drugs Revenue, 2024-2030
4.2.3 By Type - Global Dasatinib Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Dasatinib Drugs Sales & Forecasts
4.3.1 By Type - Global Dasatinib Drugs Sales, 2018-2023
4.3.2 By Type - Global Dasatinib Drugs Sales, 2024-2030
4.3.3 By Type - Global Dasatinib Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Dasatinib Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Dasatinib Drugs Market Size, 2022 & 2030
5.1.2 CML
5.1.3 ALL
5.2 By Application - Global Dasatinib Drugs Revenue & Forecasts
5.2.1 By Application - Global Dasatinib Drugs Revenue, 2018-2023
5.2.2 By Application - Global Dasatinib Drugs Revenue, 2024-2030
5.2.3 By Application - Global Dasatinib Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Dasatinib Drugs Sales & Forecasts
5.3.1 By Application - Global Dasatinib Drugs Sales, 2018-2023
5.3.2 By Application - Global Dasatinib Drugs Sales, 2024-2030
5.3.3 By Application - Global Dasatinib Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Dasatinib Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Dasatinib Drugs Market Size, 2022 & 2030
6.2 By Region - Global Dasatinib Drugs Revenue & Forecasts
6.2.1 By Region - Global Dasatinib Drugs Revenue, 2018-2023
6.2.2 By Region - Global Dasatinib Drugs Revenue, 2024-2030
6.2.3 By Region - Global Dasatinib Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Dasatinib Drugs Sales & Forecasts
6.3.1 By Region - Global Dasatinib Drugs Sales, 2018-2023
6.3.2 By Region - Global Dasatinib Drugs Sales, 2024-2030
6.3.3 By Region - Global Dasatinib Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Dasatinib Drugs Revenue, 2018-2030
6.4.2 By Country - North America Dasatinib Drugs Sales, 2018-2030
6.4.3 US Dasatinib Drugs Market Size, 2018-2030
6.4.4 Canada Dasatinib Drugs Market Size, 2018-2030
6.4.5 Mexico Dasatinib Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Dasatinib Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Dasatinib Drugs Sales, 2018-2030
6.5.3 Germany Dasatinib Drugs Market Size, 2018-2030
6.5.4 France Dasatinib Drugs Market Size, 2018-2030
6.5.5 U.K. Dasatinib Drugs Market Size, 2018-2030
6.5.6 Italy Dasatinib Drugs Market Size, 2018-2030
6.5.7 Russia Dasatinib Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Dasatinib Drugs Market Size, 2018-2030
6.5.9 Benelux Dasatinib Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Dasatinib Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Dasatinib Drugs Sales, 2018-2030
6.6.3 China Dasatinib Drugs Market Size, 2018-2030
6.6.4 Japan Dasatinib Drugs Market Size, 2018-2030
6.6.5 South Korea Dasatinib Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Dasatinib Drugs Market Size, 2018-2030
6.6.7 India Dasatinib Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Dasatinib Drugs Revenue, 2018-2030
6.7.2 By Country - South America Dasatinib Drugs Sales, 2018-2030
6.7.3 Brazil Dasatinib Drugs Market Size, 2018-2030
6.7.4 Argentina Dasatinib Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Dasatinib Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Dasatinib Drugs Sales, 2018-2030
6.8.3 Turkey Dasatinib Drugs Market Size, 2018-2030
6.8.4 Israel Dasatinib Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Dasatinib Drugs Market Size, 2018-2030
6.8.6 UAE Dasatinib Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Dasatinib Drugs Major Product Offerings
7.1.4 Bristol-Myers Squibb Dasatinib Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Bristol-Myers Squibb Key News & Latest Developments
7.2 LUCIUS Pharma
7.2.1 LUCIUS Pharma Company Summary
7.2.2 LUCIUS Pharma Business Overview
7.2.3 LUCIUS Pharma Dasatinib Drugs Major Product Offerings
7.2.4 LUCIUS Pharma Dasatinib Drugs Sales and Revenue in Global (2018-2023)
7.2.5 LUCIUS Pharma Key News & Latest Developments
8 Global Dasatinib Drugs Production Capacity, Analysis
8.1 Global Dasatinib Drugs Production Capacity, 2018-2030
8.2 Dasatinib Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Dasatinib Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dasatinib Drugs Supply Chain Analysis
10.1 Dasatinib Drugs Industry Value Chain
10.2 Dasatinib Drugs Upstream Market
10.3 Dasatinib Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dasatinib Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Dasatinib Drugs in Global Market
Table 2. Top Dasatinib Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Dasatinib Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Dasatinib Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Dasatinib Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Dasatinib Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Dasatinib Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Dasatinib Drugs Product Type
Table 9. List of Global Tier 1 Dasatinib Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dasatinib Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Dasatinib Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Dasatinib Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Dasatinib Drugs Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Dasatinib Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Dasatinib Drugs Sales (K Units), 2024-2030
Table 16. By Application ? Global Dasatinib Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Dasatinib Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Dasatinib Drugs Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Dasatinib Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Dasatinib Drugs Sales (K Units), 2024-2030
Table 21. By Region ? Global Dasatinib Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Dasatinib Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Dasatinib Drugs Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Dasatinib Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Dasatinib Drugs Sales (K Units), 2024-2030
Table 26. By Country - North America Dasatinib Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Dasatinib Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Dasatinib Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Dasatinib Drugs Sales, (K Units), 2024-2030
Table 30. By Country - Europe Dasatinib Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Dasatinib Drugs Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Dasatinib Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Dasatinib Drugs Sales, (K Units), 2024-2030
Table 34. By Region - Asia Dasatinib Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Dasatinib Drugs Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Dasatinib Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Dasatinib Drugs Sales, (K Units), 2024-2030
Table 38. By Country - South America Dasatinib Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Dasatinib Drugs Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Dasatinib Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Dasatinib Drugs Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Dasatinib Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Dasatinib Drugs Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Dasatinib Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Dasatinib Drugs Sales, (K Units), 2024-2030
Table 46. Bristol-Myers Squibb Company Summary
Table 47. Bristol-Myers Squibb Dasatinib Drugs Product Offerings
Table 48. Bristol-Myers Squibb Dasatinib Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Bristol-Myers Squibb Key News & Latest Developments
Table 50. LUCIUS Pharma Company Summary
Table 51. LUCIUS Pharma Dasatinib Drugs Product Offerings
Table 52. LUCIUS Pharma Dasatinib Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. LUCIUS Pharma Key News & Latest Developments
Table 54. Dasatinib Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 55. Global Dasatinib Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 56. Global Dasatinib Drugs Production by Region, 2018-2023 (K Units)
Table 57. Global Dasatinib Drugs Production by Region, 2024-2030 (K Units)
Table 58. Dasatinib Drugs Market Opportunities & Trends in Global Market
Table 59. Dasatinib Drugs Market Drivers in Global Market
Table 60. Dasatinib Drugs Market Restraints in Global Market
Table 61. Dasatinib Drugs Raw Materials
Table 62. Dasatinib Drugs Raw Materials Suppliers in Global Market
Table 63. Typical Dasatinib Drugs Downstream
Table 64. Dasatinib Drugs Downstream Clients in Global Market
Table 65. Dasatinib Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Dasatinib Drugs Segment by Type in 2022
Figure 2. Dasatinib Drugs Segment by Application in 2022
Figure 3. Global Dasatinib Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Dasatinib Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Dasatinib Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Dasatinib Drugs Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Dasatinib Drugs Revenue in 2022
Figure 9. By Type - Global Dasatinib Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Dasatinib Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Dasatinib Drugs Sales Market Share, 2018-2030
Figure 12. By Type - Global Dasatinib Drugs Price (USD/Unit), 2018-2030
Figure 13. By Application - Global Dasatinib Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Dasatinib Drugs Revenue Market Share, 2018-2030
Figure 15. By Application - Global Dasatinib Drugs Sales Market Share, 2018-2030
Figure 16. By Application - Global Dasatinib Drugs Price (USD/Unit), 2018-2030
Figure 17. By Region - Global Dasatinib Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Dasatinib Drugs Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Dasatinib Drugs Revenue Market Share, 2018-2030
Figure 20. By Region - Global Dasatinib Drugs Sales Market Share, 2018-2030
Figure 21. By Country - North America Dasatinib Drugs Revenue Market Share, 2018-2030
Figure 22. By Country - North America Dasatinib Drugs Sales Market Share, 2018-2030
Figure 23. US Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Dasatinib Drugs Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Dasatinib Drugs Sales Market Share, 2018-2030
Figure 28. Germany Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. France Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Dasatinib Drugs Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Dasatinib Drugs Sales Market Share, 2018-2030
Figure 37. China Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. India Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Dasatinib Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - South America Dasatinib Drugs Sales Market Share, 2018-2030
Figure 44. Brazil Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Dasatinib Drugs Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Dasatinib Drugs Sales Market Share, 2018-2030
Figure 48. Turkey Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Dasatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 52. Global Dasatinib Drugs Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Dasatinib Drugs by Region, 2022 VS 2030
Figure 54. Dasatinib Drugs Industry Value Chain
Figure 55. Marketing Channels
